|
Subjects | Evaluated markers | Main findings | Ref. |
|
50 newborns: 30 sepsis/20 controls | Serum XO, CPK, SOD, GPx, PO, MDA, uric acid, albumin | Increased XO, CPK, SOD, GPx, MDA, reduced PO, uric acid, albumin in sepsis versus controls | [49] |
|
50 newborns: 30 sepsis/20 controls | Serum TNF-alpha, SOD, GPx | Increased TNF-alpha, SOD, GPx in sepsis versus controls 5-fold increase of TNF-alpha but no differences in SOD, GPx in septic shock versus nonseptic shock | [50] |
|
128 newborns: 44 sepsis/84 controls | Serum MDA, SOD, GPx, CAT, uric acid, albumin | Increased MDA, SOD, GPx, CAT, reduced uric acid, albumin in sepsis versus controls Increased MDA, SOD, GPx, CAT, reduced uric acid, albumin in sepsis-related death versus sepsis survivors | [51] |
|
120 preterm newborns: 20 proven EOS/20 clinical EOS/80 controls Mean GA: 30 wks | Cord blood IL-6, IL-10-TBARS, protein carbonyls | Increased IL-6, IL-10, TBARS, protein carbonyls in proven and clinical sepsis versus controls Increased TBARS, IL-6 in proven versus clinical sepsis TBARS and IL-6 best biomarkers for the diagnosis of sepsis (AUC 0.88) TBARS is the only marker independently associated with EOS | [54] |
|
120 preterm newborns | Serum IL-6, IL-10, TBARS, protein carbonyls | IL-6 and TBARS showed mild to moderate correlation with sepsis severity score No markers predict sepsis-related mortality | [55] |
|
30 term newborns: 20 sepsis/10 controls | Serum MDA + 4-HDA | 2-fold increase of MDA + 4-HDA in septic patients versus controls | [63] |
|
52 newborns with LOS: 27 clinical/25 proven LOS Mean GA: 35 wks | Erythrocyte GPx, TrxR, SOD, CAT, selenium, and glutathione; SePP; plasma lipid peroxidation markers | Increased GPx in clinical sepsis versus controls: Reduced TrxR in proven sepsis versus controls: Increased SOD, CAT, lipid peroxidation, reduced selenium, SePP, glutathione in clinical and proven sepsis versus controls | [64] |
|
70 newborns: 35 LOS/35 controls Mean GA: 36 wks | Serum PON-1, TOS, TAS, OSI | Increased TAS/TOS/OSI; reduced PON-1 in sepsis pretreatment versus posttreatment. Increased TAS/TOS/OSI; reduced PON-1 in sepsis pretreatment versus controls | [65] |
|
65 preterm newborns 31 sepsis/34 controls Mean GA: 34 wks | Erythrocyte SOD, CAT, GPx, GR | Increased CAT at 60 days following sepsis diagnosis in sepsis versus controls | [68] |
|